Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D019386 |
Alendronate |
Alendronate affects the expression of HOXA1 mRNA | affects expression | 16079270
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HOXA1 mRNA | affects expression | 16483693
|
D000841 |
Anisomycin |
Anisomycin promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA] | increases expression|increases reaction | 16038797
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HOXA1 mRNA | affects cotreatment|increases expression | 18164116
|
D003520 |
Cyclophosphamide |
HOXA1 protein affects the susceptibility to Cyclophosphamide | affects response to substance | 16217747
|
D003840 |
Deoxycholic Acid |
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of HOXA1 mRNA | affects cotreatment|increases expression | 16556975
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HOXA1 mRNA | affects cotreatment|increases expression | 18164116
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of HOXA1 mRNA | affects expression | 16079270
|
C030691 |
gluconic acid |
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of HOXA1 mRNA | affects cotreatment|increases expression | 16556975
|
C533894 |
LG 100815 |
LG 100815 results in increased expression of HOXA1 mRNA | increases expression | 16951191
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of HOXA1 mRNA | increases expression | 15674843
|
C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in increased expression of HOXA1 mRNA | increases expression | 16951191
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HOXA1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D020849 |
Raloxifene |
Raloxifene affects the expression of HOXA1 mRNA | affects expression | 16079270
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [IL8 protein results in increased expression of HOXA1 mRNA polymorphism] | increases expression|increases reaction | 17218384
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HOXA1 mRNA | increases expression | 17218384 17185360
|
D014212 |
Tretinoin |
Anisomycin promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA] | increases expression|increases reaction | 16038797
|
D014212 |
Tretinoin |
Tretinoin affects the expression of HOXA1 | affects expression | 15722554
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HOXA1 | increases expression | 8838863
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HOXA1 mRNA | increases expression | 19897914 16788091 16604517 16038797
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HOXA1 mRNA | increases expression | 16989981
|
D014635 |
Valproic Acid |
Valproic Acid analog results in increased expression of HOXA1 mRNA | increases expression | 16989981
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of HOXA1 mRNA | increases expression | 16989981
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.51 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.93 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.12 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.81 | 14692618 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
6.89 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.89 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.16 | 16434500 17620307 18056438 19052882 17162532 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.16 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.60 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.62 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.54 | 15800139 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.57 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
10.22 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
10.22 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.21 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.21 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
4.98 | 10378619 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.98 | 16456186 |
MESH:C535397 |
Athabaskan brainstem dysgenesis |
marker/mechanism |
|
| |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 11091361 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 18775368 20603192 18177632 18558336 19232924 18985861 17688650 15238991 19460635 18316065 18940202 17507914 18396377 17157402 16609825 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.41 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.08 | 20046352 17594078 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.18 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.99 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.99 | 16197459 16206674 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.40 | 8888407 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.49 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.02 | 17020986 11325840 15093573 18234424 18323546 17388661 16978400 12006526 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.02 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.02 | 15758505 17952589 17893378 15775269 17440819 16837676 16912660 17049068 15572757 17242785 17261762 17595753 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.02 | 16166294 16443354 16873071 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.18 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
5.01 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.61 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.19 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
4.71 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.71 | 20214788 18978308 17173139 17162532 3084413 18056438 18210153 18691550 18506893 20524982 19919837 16698587 17055752 11831363 17978847 16540662 16569478 18494052 20727157 10737359 18971187 20432363 17138121 19418558 18788625 17428255 17761372 16830150 19539802 16681979 19208518 20101231 16328049 19107877 16935385 20935162 19701751 16807293 19052882 20512989 20514400 19383236 19171122 18785209 16502159 19519916 10672840 19394651 18393292 20084675 16878318 18665156 16288022 20007298 19335982 19822196 3581430 21159647 16779866 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.71 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.91 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.54 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.29 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.08 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.45 | 15775269 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.09 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.86 | 17174075 2727394 21159647 7505956 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.61 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.71 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.69 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.75 | 17681005 17333356 16105132 11677210 16919318 17110522 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.75 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.19 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.67 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.63 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.72 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Deoxycholic Acid |
3.56 | 16213893 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 10529420 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.68 | 16925845 9224671 10589399 9664655 14991402 9142499 17551590 9125849 9211117 8800419 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.68 | 16575769 8888407 17688650 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.02 | 11948286 18372110 12161096 16614059 10700343 18433785 16989017 12913760 16651033 10498854 17979934 18093676 18483878 16413132 18295254 15643279 18710439 12388444 17010015 15276878 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.16 | 17474826 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.07 | 11751995 10990075 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.22 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.19 | 20387270 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
3.94 | 17451421 17308373 15920148 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.97 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.97 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.06 | 1851702 |
MESH:D004487 |
Edema |
|
Mustard Gas |
11.58 | 11428647 11402378 9260866 11428631 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.58 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
11.58 | 15860553 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.50 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.15 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.15 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.11 | 16569247 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.23 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.17 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.95 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.94 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.59 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.31 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.08 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.18 | 9357497 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.15 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.58 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
24.73 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
24.73 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
24.73 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
24.73 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
24.73 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.92 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.14 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.53 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.01 | 17312396 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.53 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.05 | 16376943 11014644 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.19 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.19 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.90 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.54 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.54 | 20558911 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.30 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.56 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.01 | 16221962 19176532 18467677 19772884 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.79 | 17606976 16135485 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.89 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Alendronate |
8.37 | 16769263 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.37 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.58 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.87 | 15787275 17577099 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16569931 16945680 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.36 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
6.88 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.88 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.24 | 18785209 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
5.24 | 9260866 16001271 8975870 9357497 11428620 11402378 17524151 11428647 11428631 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.63 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.78 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.90 | 17551590 15992940 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.50 | 16973256 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.59 | 10602166 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.59 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.50 | 17802794 18587576 17008537 17658394 18172266 17296974 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.09 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.70 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.89 | 19850784 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.89 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.15 | 17368321 9834237 16140955 19035177 17294898 17649720 15748426 17712046 16331271 17107899 16823087 16788101 12679006 16891316 17217047 17361223 16766008 17339181 17301526 19642359 17506722 19075265 19029980 16935935 19225113 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.99 | 10052129 11830472 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.31 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.82 | 18522880 19638242 18665156 18407596 20032147 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.34 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.34 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.10 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
7.48 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
7.48 | 19690152 2862719 18644402 19551842 15175105 20434301 20452335 20583210 18977376 19833225 18754104 19255062 19638242 19996281 12112319 19256749 19812893 9163691 19090486 20501860 20101389 21071580 20137499 21167192 12771043 20492335 19294768 10737359 18648771 19642983 19499222 20405173 19254457 20118626 19427195 18978307 19073162 19850985 21278145 2422723 19426721 15885732 21047994 16942905 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.48 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
10.16 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Deoxycholic Acid |
10.16 | 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.16 | 18775883 16842330 19539802 18282651 18079962 17174075 16267830 18164116 19009564 18093689 18544905 19004024 3124819 2563599 19126423 18253720 18308698 19519916 17942915 21159647 9362446 17854601 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
3.45 | 18161513 18702808 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.29 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.60 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
2.60 | 8781369 3148597 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
3.84 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.60 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.17 | 11911406 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.78 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.94 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.81 | 16388313 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.44 | 16940565 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.19 | 18803445 18765137 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.58 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.44 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.03 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.40 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.40 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.14 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.95 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.58 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.57 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
8.33 | 18854779 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.33 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.33 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
marker/mechanism |
|
| 10529420 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.79 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.31 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.31 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.64 | 8761367 16115947 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.34 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.91 | 8761367 12837982 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.15 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
9.55 | 8291058 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
9.55 | 7688884 16761898 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.73 | 16517039 |
MESH:D010024 |
Osteoporosis |
|
Alendronate |
7.80 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.80 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.23 | 17823083 17893378 15758505 15579764 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.35 | 16936753 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
7.05 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
Tretinoin |
7.05 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
8.71 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
8.71 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.71 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.80 | 15727166 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.55 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.80 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
3.85 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.65 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.65 | 16220300 16536755 15731164 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.61 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
9.59 | 16919318 15861022 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
9.59 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.57 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.81 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
6.01 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
6.01 | 17894541 10334151 17266442 17720292 17620002 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.58 | 15770314 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.89 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.89 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.83 | 16636934 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.74 | 11044598 15475178 3137016 16876388 1511512 17978042 14763951 11738929 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.71 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.61 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.97 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.53 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.78 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.57 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.42 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.42 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.82 | 16837676 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.08 | 12837982 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.18 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.18 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.24 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.79 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.26 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.23 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.54 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.52 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
5.52 | 17572228 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.66 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.68 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.64 | 16752155 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.24 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.07 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.58 | 16343187 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.97 | 16287080 |